Weak economic evidence for WHO’s essential cancer medicines for Africa
Introduction The WHO Model Lists of Essential Medicines (MLEM and MLEMc) guide national medicine selection, particularly in low-income and lower middle-income countries (LMICs). Concerns exist about the adequacy and transferability of economic evidence supporting recent cancer medicine additions.Met...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2026-05-01
|
| סדרה: | BMJ Global Health |
| גישה מקוונת: | https://gh.bmj.com/content/11/5/e022533.full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|